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Abstract The fiber protein of adenovirus consists of a C-
terminal globular head, a shaft and a short N-terminal tail. The
crystal structure of a stable domain comprising the head plus a
part of the shaft of human adenovirus type 2 fiber has recently
been solved at 2.4 Aî resolution [van Raaij et al. (1999) Nature
401, 935^938]. A peptide corresponding to the portion of the
shaft immediately adjacent to the head (residues 355^396) has
been synthesized chemically. The peptide failed to assemble
correctly and instead formed amyloid-type fibrils as assessed by
electron microscopy, Congo red binding and X-ray diffraction.
Peptides corresponding to the fiber shaft could provide a model
system to study mechanisms of amyloid fibril formation.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Numerous diseases such as Alzheimer’s disease, maturity
onset diabetes and transmissible spongiform encephalopathies
are associated with deposition of insoluble ¢brils named amy-
loid ¢brils in tissues [2]. Current models of amyloid ¢brils
propose that the ¢brils adopt a cross-L-structure with L-
strands perpendicular to the ¢ber axis [3,4]. This cross-L-struc-
ture seems to be a structural motif common to all amyloid
¢brils independent of sequence or structural folds of the pro-
teins the ¢brils originate from [4]. There is also a growing
consensus that amyloid ¢brils can evolve from common pre-
cursors, i.e. partially folded intermediates in the unfolding or
refolding pathway of proteins [5^8]. Aggregate formation
from partially folded intermediates that fail to proceed
down to the correct folding pathway is also a common mech-
anism underlying inclusion body formation in laboratory and
industry [9^14]. Despite a growing body of studies, the factors
that govern the partition of polypeptide chains between cor-
rect folding and assembly on the one hand and misfolding and
misassembly on the other remain poorly understood.
In the particular case of ¢brillar proteins, for example col-
lagen, correct chain assembly needs a registration signal. Dur-
ing collagen biosynthesis, the pro-collagen globular regions
serve to properly align the three chains and are subsequently
cleaved to give the mature, triple helical chain [15,16]. When
the mature collagen is heated in vitro, the three chains un-
wind; upon subsequent cooling, segments of the triple helix
reform, either within the same chain or between di¡erent
chains, but they are out of register. The result is the formation
of an intermolecular network that leads to the gelatin gel [15].
One of the approaches in studying protein folding consists
in using synthetic peptides as models. Synthetic peptides cor-
responding to collagen sequences have opened a new dimen-
sion in the understanding of its folding and also of misfolding
and misassembly associated with collagen diseases [17]. A
model peptide that forms polymers that share at least some
of the properties of the amyloid ¢brils is the subject of this
report. The peptide originates from a sequence of the adeno-
virus ¢ber protein. This trimeric protein is the cell attachment
molecule of the virus, and consists of a globular head or knob,
a shaft, and a short N-terminal tail anchored in the virus
capsid [18,19]. The sequence of the shaft reveals pseudorepeats
of 15 amino acids containing conserved hydrophobic residues
and a conserved proline or glycine (Fig. 1A) [20]. The ¢ber of
human adenovirus type 2 (HAd2) has 22 such repeats making
up a total length of the shaft of 29 nm [21]. Recent folding
studies have identi¢ed a stable domain of the ¢ber comprising
the head plus ¢ve shaft repeats [22]. The crystal structure of
this stable domain has just been solved at 2.4 Aî resolution [1].
Each head monomer is an eight-stranded antiparallel L-sand-
wich, and the three monomers assemble into a three-bladed L-
propeller structure [23,24]. The crystal structure reveals a nov-
el folding motif for the shaft domain, named the triple L-spiral
[1]. The structure of each repeat comprises an extended
strand, then a type II L-turn which is followed by another
L-strand. The repeats are connected to each other by a sol-
vent-exposed variable loop (Fig. 1B). The hydrophobic resi-
dues are buried in the longitudinal hydrophobic core of the
shaft or in a second ring of stabilizing hydrophobic interac-
tions at a higher radius [1].
To study the folding of the shaft, we have synthesized a
model peptide corresponding to the C-terminal part of the
shaft in the stable domain. Hong and Engler reported in
[25] that deletion of the ¢rst 354 residues of the HAd2 ¢ber
did not prevent trimerization of the head and of the remaining
portion of the shaft when the fragment was expressed in vac-
cinia cells. Therefore, that portion of the shaft (from residues
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355 to 396, the beginning of the head) was chosen for the
sequence of the synthetic peptide.
2. Materials and methods
2.1. Chemical reagents
tert-Butyloxycarbonyl (Boc) amino acids and resin were purchased
from Neosystem (Strasbourg, France) or Novabiochem (Meudon,
France). The reagents for solid-phase peptide synthesis were obtained
from Applied Biosystems (Perkin Elmer, Courtaboeuf, France), ex-
cept dichloromethane, which was from SDS (Solvants, Documenta-
tion, Synthe'ses) (Peypin, France), as was acetonitrile for high per-
formance liquid chromatography (HPLC). 8 M Ultrapure guanidine
hydrochloride (GdnHCl) was purchased from Pierce and Congo red
was purchased from Sigma. All other chemicals were of the purest
grade available.
2.2. Solid-phase peptide synthesis
The C-terminal amide derivative of the 355^396 segment from the
HAd2 ¢ber protein was synthesized by the stepwise solid-phase meth-
od [26] using an Applied Biosystems 430A automated synthesizer.
Synthesis was performed on a 4-methyl benzhydrylamine resin, and
the Boc group was used for K-amino protection. All couplings were
performed by the dicyclohexylcarbodiimide/1-hydroxybenzotriazole
method, using N-methylpyrrolidone and dimethylsulfoxide as cou-
pling solvents, according to the protocol de¢ned by Applied Biosys-
tems. Cleavage of the peptide from the resin and simultaneous depro-
tection of side chains were carried out in an HF cleavage apparatus
(Peptide Institute, Japan) using lique¢ed HF in the presence of anisole
and dimethylsul¢de as scavengers for 1 h at 35‡C.
The peptide was puri¢ed by reverse-phase HPLC on a Vydac (Hes-
peria, USA) C18 column (2.2U25 cm) by means of a linear gradient
of 10^65% acetonitrile in 0.1% aqueous tri£uoroacetic acid over 30
min (£ow rate 16 ml/min). Homogeneous fractions were pooled and
freeze-dried. The pronounced tendency of the peptide to aggregate
during the puri¢cation steps hampered considerably the puri¢cation
process and resulted in a low ¢nal yield of the material. The purity
and identity of the synthetic peptide were assessed by reverse-phase
HPLC and electrospray mass spectrometry [27]. The experimental
mass was 4309.63 þ 0.2 (calculated mass 4309.83).
2.3. Electron microscopy
The peptide in 6 M GdnHCl at a concentration of 10 mg/ml was
diluted to 0.4 mg/ml or 0.1 mg/ml with a pH 7 phosphate bu¡er
(50 mM sodium phosphate, 1 mM EDTA). Alternatively, the peptide
in 6 M GdnHCl was diluted to 0.1 mg/ml with a pH 4 acetate bu¡er
(50 mM sodium acetate, 1 mM EDTA) or dissolved directly into pH 4
acetate bu¡er to the same ¢nal concentration. The peptide solution
was adsorbed to the clean side of a carbon ¢lm on mica, washed with
bu¡er without GdnHCl and negatively stained with 1% sodium silico-
tungstate. Micrographs were taken with a JEOL 1200 XII microscope
and the magni¢cation was calibrated with negatively stained crystals
of catalase.
2.4. Congo red staining and polarized light microscopy
Fibrils were stained with 10 WM Congo red and were sedimented at
10 000Ug. They were subsequently washed twice with phosphate bu¡-
er and then placed on glass slides. The samples were studied with a
Zeiss Axiophot microscope equipped with crossed polars.
2.5. X-ray di¡raction
To obtain the X-ray di¡raction pattern, a peptide lacking the N-
terminal asparagine residue (355) was used. This peptide could be
obtained in higher yields but otherwise presents the same behavior
in terms of aggregate formation, electron microscopy appearance and
Congo red staining as the original peptide. Samples were prepared by
dissolving the peptide (10 mg/ml concentration) in acetate bu¡er and
forming droplets between the ends of two glass rods. The distance
between the glass rods was gradually increased to encourage align-
ment of the ¢brils while drying. The droplets were dried over a period
of approximately 12 h, forming samples that were typically about
100^200 Wm thick and 1^2 mm long.
X-ray di¡raction patterns were recorded using a Siemens rotating
anode generator that provided X-rays with a wavelength of 1.5418 Aî .
The detector was a Mar Research online image plate system. Expo-
sure times ranged between 4 and 8 h.
3. Results and discussion
The synthetic peptide has a calculated pI of 8.4 at neutral
pH; 12 out of its 42 residues are hydrophobic and seven are
glycine. The puri¢ed peptide proved to be insoluble in bu¡er
at neutral pH (50 mM sodium phosphate with 1 mM EDTA,
pH 7) at a concentration of 10 mg/ml. In contrast, it was
soluble in 6 M GdnHCl at the same concentration. When
dissolved in 6 M GdnHCl and subsequently diluted to a con-
centration of 0.1 or 0.4 mg/ml with phosphate bu¡er, it
formed ¢brils. Fibrils were also formed when the peptide
Fig. 1. Sequence of the synthetic shaft peptide 355^396 and struc-
ture of the corresponding segment within the native HAd2 ¢ber.
(A) Sequence of the peptide of the HAd2 ¢ber shaft showing the
approximately 15 residue repeats from residue 355 to 392. The last
four amino acids are in italics and are not part of a repeat but con-
nect the shaft to the head of the HAd2 ¢ber. The conserved second-
ary structure of the repeats is shown above the sequence with L for
loop, L for L-strand and T for L-turn. The conserved sequence char-
acteristics of the repeats are shown below the sequence with X for
any residue, P for hydrophobic residues and G for glycine. For the
sequence of the ¢ber stable domain, see [22]. (B) Structure of the
peptide within the native shaft segment (courtesy of Drs. Mark van
Raaij and Stephen Cusack, EMBL Grenoble). One of the strands of
the trimeric shaft is shown in black and the other two in gray. The
structure of the peptide in the native shaft from N- to C-terminus
consists of a L-strand, a type II L-turn, another L-strand and a sur-
face-exposed loop leading to a second repeat with the same struc-
ture. The peptide ends with a relatively short L-strand plus four res-
idues in random coil connecting the shaft to the head of the ¢ber.
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was directly dissolved into 50 mM acetate bu¡er, 1 mM
EDTA, pH 4, as well as when the peptide was ¢rst dissolved
in 6 M GdnHCl and subsequently diluted into acetate bu¡er.
Fibril formation could be detected by light scattering, follow-
ing the UV absorbance at 340 nm or by right-angle scattering
at 400 nm in a £uorimeter. In contrast with the stable domain
of the native adenovirus ¢ber shaft, which is resistant to so-
dium dodecyl sulfate (SDS) [22], the ¢bril structure was not
resistant to this detergent since it ran as monomers on SDS^
polyacrylamide gel electrophoresis gels with or without prior
heat treatment (not shown).
Electron microscopy of the freeze-dried peptide suspended
in pH 7 bu¡er showed very large, unstructured aggregates, in
agreement with the fact that the peptide is not soluble under
these conditions. In contrast, the peptide solubilized in 6 M
GdnHCl and subsequently diluted into pH 7 bu¡er to a ¢nal
concentration of 0.4 mg/ml showed thin ¢laments with a
length of 200^500 nm that had a strong tendency to coalesce
and form large tangles (Fig. 2B). Samples that were diluted
out of GdnHCl to a ¢nal concentration of 0.1 mg/ml revealed
much longer unbranching strands that resemble twisted rib-
bons (Fig. 2A). Very similar ¢laments were observed after
dilution to both pH 7 and pH 4 and also after direct dissolv-
ing in pH 4 bu¡er, indicating that the length of the ¢laments
is mainly in£uenced by the peptide concentration at which
they are formed. Higher magni¢cation of a number of ¢la-
ments is shown in Fig. 2C. These images seem to provide
support for the occurrence of thin proto¢laments that asso-
ciate sideways to form twisted ribbons with variable widths,
depending on how many proto¢laments are present. The
thickness of the nodules of all ribbons was the same:
3.7 þ 0.5 nm (n = 18). The distance between the nodules, i.e.
half of the helical pitch, was 84 þ 11 nm (n = 47). Similar
twisted ribbons have been observed in amyloid ¢brils formed
by fusion peptides (thickness about 5 nm, half pitch of about
100 nm; [28]), an SH3 domain (half pitch 54^66 nm; [29]) and
various Alzheimer’s disease-related peptides (thicknesses of
3.5^4 nm to 5.5^6 nm; [30]).
When Congo red was added to the ¢bril-forming peptide
solutions, the absorption spectrum of the dye was broad with
a maximum at 506 nm, compared to an absorption spectrum
with a maximum at 492 nm of the dye alone in bu¡er. Visible
red ¢brils were observed at the bottom of the test tube. To
view the ¢brils under a light microscope, the sample needed to
be concentrated in a microfuge; as a result, the ¢brils were
found to coalesce into plaques (Fig. 3A). When viewed under
polarized light, these plaques exhibited birefringence, going
from red to green (Fig. 3B).
The X-ray di¡raction pattern of the ¢brils showed two ma-
jor re£ections that appear as rings due to the poor alignment
of the ¢brils. A dominant sharp re£ection was observed at a
position corresponding to 4.75 Aî and a weaker, more di¡use
one was observed at 9.7 Aî (Fig. 4). Those re£ections are
characteristic of the cross-L-conformation described for nu-
merous amyloid ¢brils, where L-sheets run parallel to the ¢l-
ament axis with their constituent L-strands being perpendicu-
lar to the main ¢bril axis [31]. In well-oriented amyloid ¢bril
samples, the 4.75 Aî re£ection is meridional in character and
Fig. 2. Electron microscopy of ¢brils. Electron micrographs of ¢brils
negatively stained with sodium silicotungstate. (A) Fibrils formed
after dilution of peptide in 6 M GdnHCl into pH 7 bu¡er to a ¢nal
concentration of 0.1 mg/ml. (B) Fibrils formed in the same way
but after dilution to 0.4 mg/ml. (C) Higher magni¢cation images of
¢brils taken from the same sample as in A. Note the helical repeat
structure. The magni¢cation of A and B is the same, as indicated by
the bar in B. The magni¢cation of C is two times higher than that
in A and B, as indicated by the bar in C.
Fig. 3. Photomicrographs of peptide ¢brils stained with Congo red.
(A) Bright ¢eld, (B) polarized light. Magni¢cation is 100U.
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corresponds to the interstrand spacing in the cross-L-confor-
mation, while the 9.7 Aî one is equatorial and corresponds to
the intersheet spacing. Although the method of sample prep-
aration that was used is designed to produce aligned samples
in which the ¢laments are expected to be predominantly par-
allel, none of the di¡raction patterns that have been obtained
so far has shown good orientation. Attempts to improve the
ordering in these ¢bers are currently in progress so that a
detailed ¢ber di¡raction analysis can be undertaken.
These results show that the HAd2 model peptide studied is
capable of forming ¢brils that share common characteristics
with well-characterized amyloid ¢brils, namely the ability to
form insoluble strands of indeterminate length that are bire-
fringent when stained with Congo red and display two char-
acteristic major re£ections in X-ray di¡raction patterns. The
conformation of the peptide within the ¢brils is probably dif-
ferent from the one within the native adenovirus ¢ber shaft. It
is possible that the peptide adopts a partially folded confor-
mation [32] that could subsequently convert to the cross-L-
conformation described for numerous amyloid structures
[31,33].
The adenovirus ¢ber head is known to be essential for its
trimerization as deletions or mutations in this part of the
protein hinder the trimerization process in vivo [25,34]. The
¢ber head might act as a registration signal necessary for the
three chains to align and fold together, thus playing a role
analogous to that of the pro-collagen peptides in collagen
folding [15,16,35]. A plausible model to explain ¢bril forma-
tion would be that in the absence of the head to establish
registration, oligomers can form through out of register inter-
actions leading to long unbranched sub-proto¢laments. These
sub-proto¢laments could then associate into proto¢laments as
proposed for amyloid ¢brils formed from other proteins or
peptides [3,4].
In order to address these questions, it will be necessary to
obtain higher resolution structural information on ¢bril archi-
tecture, especially using X-ray di¡raction and cryo-electron
microscopy. It will also be interesting to study the folding
and polymerization behavior of other peptides derived from
the HAd2 ¢ber shaft, with di¡erent lengths and overall
charges. We anticipate that these peptides can serve as model
systems for the further understanding of the interplay between
assembly and misassembly processes in L-sheet structures.
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